Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Israeli Discovery Might Enable Early Detection of Uterine and Colon Cancers
Error: Contact form not found.
by JNS.org
A view of Hadassah Medical Center in Jerusalem. Photo: Wikimedia Commons.
JNS.org – A recent discovery in a study by Israeli researchers might allow for the early detection and possible prevention of colon and uterine cancers.
Among populations of different backgrounds in Israel, the study—conducted by researchers at Hadassah Medical Center in Jerusalem, Rabin Medical Center in Petach Tikva, and Sourasky Medical Center in Tel Aviv—identified a genetic mutation related to Lynch syndrome that increases the risk of colon and uterine cancers. The populations affected by the mutation include Jews of European, Iranian, Afghan, and Georgian descent.
Being able to detect a mutation that is characteristic of a certain population makes identifying the syndrome much simpler and cheaper.
“The study is of immense importance in the prevention and early treatment of cancer,” said Prof. Tamar Peretz, the senior oncologist and acting director-general of Hadassah Hospital, according to Israel Hayom. “Identifying the genetic mutation allows us to find subsets of healthy people who carry that mutation, and put them on an early prevention and observation program. Early detection of cancer is one of the most important tools in healing the deadly disease.”
